The clinical utility of C-peptide measurement in the care of patients with diabetes.

RPEP-022032013RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
The clinical utility of C-peptide measurement in the care of patients with diabetes.
Published In:
Diabetic medicine : a journal of the British Diabetic Association, 30(7), 803-17 (2013)
Database ID:
RPEP-02203

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-02203·https://rethinkpeptides.com/research/RPEP-02203

APA

Jones, A G; Hattersley, A T. (2013). The clinical utility of C-peptide measurement in the care of patients with diabetes.. Diabetic medicine : a journal of the British Diabetic Association, 30(7), 803-17. https://doi.org/10.1111/dme.12159

MLA

Jones, A G, et al. "The clinical utility of C-peptide measurement in the care of patients with diabetes.." Diabetic medicine : a journal of the British Diabetic Association, 2013. https://doi.org/10.1111/dme.12159

RethinkPeptides

RethinkPeptides Research Database. "The clinical utility of C-peptide measurement in the care of..." RPEP-02203. Retrieved from https://rethinkpeptides.com/research/jones-2013-the-clinical-utility-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.